BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis. Cancer Med 2020;9:361-73. [PMID: 31693304 DOI: 10.1002/cam4.2673] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Hu C, Huang J, Xiang K, Li Z, Qu J, Chen Y, Yang B, Qu X, Liu Y, Zhang G, Wen T. A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort. Front Oncol 2021;11:591009. [PMID: 33738248 DOI: 10.3389/fonc.2021.591009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Zhu YJ, Chen Y, Hu HY, Zhou YW, Zhu YT, Liu JY. Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis. Front Oncol 2020;10:1681. [PMID: 33123459 DOI: 10.3389/fonc.2020.01681] [Reference Citation Analysis]
3 Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis. Cancer Med 2020;9:361-73. [PMID: 31693304 DOI: 10.1002/cam4.2673] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
4 Mihai MM, Ion A, Giurcăneanu C, Nițipir C, Popa AM, Chifiriuc MC, Popa MI, Říčař J, Popa LG, Sârbu I, Lazăr V. The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients. J Clin Med 2021;10:3219. [PMID: 34362003 DOI: 10.3390/jcm10153219] [Reference Citation Analysis]
5 Scripcariu V, Ciobanu Apostol DG, Dumitrescu GF, Turliuc MD, Sava A. Clinical, histopathological and immunohistochemical features of brain metastases originating in colorectal cancer: a series of 27 consecutive cases. Rom J Morphol Embryol 2020;61:81-93. [PMID: 32747898 DOI: 10.47162/RJME.61.1.09] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Contino KF, Yadav H, Shiozawa Y. The gut microbiome can be a potential regulator and treatment target of bone metastasis. Biochem Pharmacol 2022;:114916. [PMID: 35041811 DOI: 10.1016/j.bcp.2022.114916] [Reference Citation Analysis]
7 Jeon HD, Han YH, Mun JG, Yoon DH, Lee YG, Kee JY, Hong SH. Dehydroevodiamine inhibits lung metastasis by suppressing survival and metastatic abilities of colorectal cancer cells. Phytomedicine 2021;:153809. [PMID: 34782203 DOI: 10.1016/j.phymed.2021.153809] [Reference Citation Analysis]
8 Sumransub N, Vantanasiri K, Prakash A, Lou E. Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? Mol Ther Oncolytics 2021;22:1-12. [PMID: 34307839 DOI: 10.1016/j.omto.2021.05.001] [Reference Citation Analysis]
9 Huang C, Ou R, Chen X, Zhang Y, Li J, Liang Y, Zhu X, Liu L, Li M, Lin D, Qiu J, Liu G, Zhang L, Wu Y, Tang H, Liu Y, Liang L, Ding Y, Liao W. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC. J Exp Clin Cancer Res 2021;40:304. [PMID: 34583750 DOI: 10.1186/s13046-021-02108-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rasic P, Jovanovic-Tucovic M, Jeremic M, Djuricic SM, Vasiljevic ZV, Milickovic M, Savic D. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(8): 799-821 [PMID: 34457187 DOI: 10.4251/wjgo.v13.i8.799] [Reference Citation Analysis]
11 Cherri S, Libertini M, Zaniboni A. New drugs for the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1551-1560 [PMID: 34853636 DOI: 10.4251/wjgo.v13.i11.1551] [Reference Citation Analysis]
12 Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S, Line PD, Adam R. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol 2021;6:933-46. [PMID: 34506756 DOI: 10.1016/S2468-1253(21)00219-3] [Reference Citation Analysis]
13 Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg A, Probst P, Hoffmann K. Pushing the limit of liver regeneration - Safety and survival after monosegment-ALPPS: systematic review and individual patient data meta-analysis. HPB (Oxford) 2021:S1365-182X(21)00609-2. [PMID: 34330644 DOI: 10.1016/j.hpb.2021.06.427] [Reference Citation Analysis]
14 Villota H, Moreno-Ceballos M, Santa-González GA, Uribe D, Castañeda ICH, Preciado LM, Pedroza-Díaz J. Biological Impact of Phenolic Compounds from Coffee on Colorectal Cancer. Pharmaceuticals (Basel) 2021;14:761. [PMID: 34451858 DOI: 10.3390/ph14080761] [Reference Citation Analysis]
15 Sridharan K, Rathore B, Yousuf M, Reddy Rachamalla HK, Jinka S, Jaggarapu MMCS, Banerjee R. Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor. Mol Pharm 2021;18:1208-28. [PMID: 33371687 DOI: 10.1021/acs.molpharmaceut.0c01091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Attalla K, Duzgol C, McLaughlin L, Flynn J, Ostrovnaya I, Russo P, Bilsky MH, Hakimi AA, Moss NS. The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination. Urol Oncol 2021;39:196.e9-196.e14. [PMID: 33423935 DOI: 10.1016/j.urolonc.2020.12.008] [Reference Citation Analysis]
17 Jördens MS, Labuhn S, Luedde T, Hoyer L, Kostev K, Loosen SH, Roderburg C. Prevalence of Lung Metastases among 19,321 Metastatic Colorectal Cancer Patients in Eight Countries of Europe and Asia. Curr Oncol 2021;28:5035-40. [PMID: 34940062 DOI: 10.3390/curroncol28060423] [Reference Citation Analysis]
18 Taghizadeh H, Mader RM, Müllauer L, Erhart F, Kautzky-Willer A, Prager GW. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer. J Pers Med 2020;10:E272. [PMID: 33322358 DOI: 10.3390/jpm10040272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Davey MS, Davey MG, Ryan ÉJ, Hogan AM, Kerin MJ, Joyce M. The use of radiomic analysis of magnetic resonance imaging in predicting distant metastases of rectal carcinoma following surgical resection: A systematic review and meta-analysis. Colorectal Dis 2021. [PMID: 34536962 DOI: 10.1111/codi.15919] [Reference Citation Analysis]
20 Smit DJ, Cayrefourcq L, Haider MT, Hinz N, Pantel K, Alix-Panabières C, Jücker M. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors. Cells 2020;9:E2129. [PMID: 32962206 DOI: 10.3390/cells9092129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
21 Huang J, Chen G, Liu H, Zhang Y, Tang R, Huang Q, Fu K, Peng X, Xiao S. Surgery improves the prognosis of colon mucinous adenocarcinoma with liver metastases: a SEER-based study. BMC Cancer 2020;20:908. [PMID: 32967651 DOI: 10.1186/s12885-020-07400-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Gmeiner WH, Dominijanni A, Haber AO, Ghiraldeli LP, Caudell DL, D'Agostino R Jr, Pasche BC, Smith TL, Deng Z, Kiren S, Mani C, Palle K, Brody JR. Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties. Mol Cancer Ther 2021;20:553-63. [PMID: 33361273 DOI: 10.1158/1535-7163.MCT-20-0516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pikoulis E, Papaconstantinou D, Pikouli A, Wang J, Theodoridis C, Margonis GA. Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 2021;28:637-47. [PMID: 34115442 DOI: 10.1002/jhbp.1007] [Reference Citation Analysis]
24 Gmeiner WH. Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development. Onco Targets Ther 2021;14:2121-30. [PMID: 33790575 DOI: 10.2147/OTT.S242224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Xu Y, Huang T, Mao M, Zhai J, Chen J. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States. Laryngoscope 2021;131:E1130-8. [PMID: 32833262 DOI: 10.1002/lary.28983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ginghină O, Hudiță A, Zaharia C, Tsatsakis A, Mezhuev Y, Costache M, Gălățeanu B. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients. Materials (Basel) 2021;14:2440. [PMID: 34066710 DOI: 10.3390/ma14092440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Hu X, Chen Q, Guo H, Li K, Fu B, Chen Y, Zhao H, Wei M, Li Y, Wu H. Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis. Front Oncol 2021;11:657984. [PMID: 34490081 DOI: 10.3389/fonc.2021.657984] [Reference Citation Analysis]
28 Kristin E, Endarti D, Khoe LC, Taroeno-Hariadi KW, Trijayanti C, Armansyah A, Sastroasmoro S. Economic Evaluation of Adding Bevacizumab to Chemotherapy for Metastatic Colorectal Cancer (mCRC) Patients in Indonesia. Asian Pac J Cancer Prev 2021;22:1921-6. [PMID: 34181352 DOI: 10.31557/APJCP.2021.22.6.1921] [Reference Citation Analysis]
29 Osterlund P, Salminen T, Soveri LM, Kallio R, Kellokumpu I, Lamminmäki A, Halonen P, Ristamäki R, Lantto E, Uutela A, Osterlund E, Ovissi A, Nordin A, Heervä E, Lehtomäki K, Räsänen J, Murashev M, Aroviita L, Jekunen A, Lindvall-Andersson R, Nyandoto P, Kononen J, Lepistö A, Poussa T, Muhonen T, Ålgars A, Isoniemi H; Members of The RAXO study group are collaborators of this study and are listed in Appendix Table 4B. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. Lancet Reg Health Eur 2021;3:100049. [PMID: 34557799 DOI: 10.1016/j.lanepe.2021.100049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Liu F, Song ZM, Wang XD, Du SY, Peng N, Zhou JR, Zhang MG. Long Non-coding RNA Signature for Liver Metastasis of Colorectal Cancers. Front Cell Dev Biol 2021;9:707115. [PMID: 34307387 DOI: 10.3389/fcell.2021.707115] [Reference Citation Analysis]
32 Wang Y, Zeng Z, Tang M, Zhang M, Bai Y, Cui H, Xu Y, Guo X, Ma W, Xu G, Qi L, Wang J, Chen S, Gu D, Mao M, Wang X, Zhang C. Sex Disparities in the Clinical Characteristics, Synchronous Distant Metastasis Occurrence and Prognosis: A Pan-cancer Analysis. J Cancer 2021;12:498-507. [PMID: 33391446 DOI: 10.7150/jca.50536] [Reference Citation Analysis]
33 Parisi A, Cortellini A, Cannita K, Venditti O, Camarda F, Calegari MA, Salvatore L, Tortora G, Rossini D, Germani MM, Boccaccino A, Dell'Aquila E, Fulgenzi C, Santini D, Tursi M, Tinari N, Marino PD, Lombardi P, Keränen SR, Álvaro MH, Zurlo IV, Corsi DC, Emiliani A, Zanaletti N, Troiani T, Vitale P, Giampieri R, Merloni F, Occhipinti MA, Marchetti P, Roberto M, Mazzuca F, Ghidini M, Indini A, Garajova I, Zoratto F, Monache SD, Porzio G, Ficorella C. Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study. Cancers (Basel) 2020;12:E1259. [PMID: 32429380 DOI: 10.3390/cancers12051259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Clark AM, Allbritton NL, Wells A. Integrative microphysiological tissue systems of cancer metastasis to the liver. Semin Cancer Biol 2021;71:157-69. [PMID: 32580025 DOI: 10.1016/j.semcancer.2020.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kolbeinsson HM, Hoppe A, Walker J, Chandana S, Assifi MM, Chung M, Wright GP. Recurrence and survival after curative-intent treatment for colorectal liver metastases: Implications for adjuvant liver-directed regional chemotherapy. J Surg Oncol 2021. [PMID: 34796521 DOI: 10.1002/jso.26755] [Reference Citation Analysis]
36 Das A, Sudhaman S, Morgenstern D, Coblentz A, Chung J, Stone SC, Alsafwani N, Liu ZA, Karsaneh OAA, Soleimani S, Ladany H, Chen D, Zatzman M, Cabric V, Nobre L, Bianchi V, Edwards M, Sambira Nahum LC, Ercan AB, Nabbi A, Constantini S, Dvir R, Yalon-Oren M, Campino GA, Caspi S, Larouche V, Reddy A, Osborn M, Mason G, Lindhorst S, Bronsema A, Magimairajan V, Opocher E, De Mola RL, Sabel M, Frojd C, Sumerauer D, Samuel D, Cole K, Chiaravalli S, Massimino M, Tomboc P, Ziegler DS, George B, Van Damme A, Hijiya N, Gass D, McGee RB, Mordechai O, Bowers DC, Laetsch TW, Lossos A, Blumenthal DT, Sarosiek T, Yen LY, Knipstein J, Bendel A, Hoffman LM, Luna-Fineman S, Zimmermann S, Scheers I, Nichols KE, Zapotocky M, Hansford JR, Maris JM, Dirks P, Taylor MD, Kulkarni AV, Shroff M, Tsang DS, Villani A, Xu W, Aronson M, Durno C, Shlien A, Malkin D, Getz G, Maruvka YE, Ohashi PS, Hawkins C, Pugh TJ, Bouffet E, Tabori U. Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nat Med 2022. [PMID: 34992263 DOI: 10.1038/s41591-021-01581-6] [Reference Citation Analysis]
37 Subtil B, Cambi A, Tauriello DVF, de Vries IJM. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer. Front Immunol 2021;12:724883. [PMID: 34691029 DOI: 10.3389/fimmu.2021.724883] [Reference Citation Analysis]
38 Briede I, Balodis D, Gardovskis J, Strumfa I. Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network. Int J Mol Sci 2021;22:12891. [PMID: 34884696 DOI: 10.3390/ijms222312891] [Reference Citation Analysis]
39 Boughanem H, Martin-Nuñez GM, Torres E, Arranz-Salas I, Alcaide J, Morcillo S, Tinahones FJ, Crujeiras AB, Macias-Gonzalez M. Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival. J Pers Med 2020;10:E219. [PMID: 33187096 DOI: 10.3390/jpm10040219] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Sadetsky N, Chuo CY, Davidoff AJ. Development and evaluation of a proxy for baseline ECOG PS in advanced non-small cell lung cancer, bladder cancer, and melanoma: An electronic health record study. Pharmacoepidemiol Drug Saf 2021;30:1233-41. [PMID: 34145696 DOI: 10.1002/pds.5309] [Reference Citation Analysis]
41 Chen WT, Yang HB, Ke TW, Liao WL, Hung SY. Serum DJ-1 Is a Biomarker of Colorectal Cancer and DJ-1 Activates Mitophagy to Promote Colorectal Cancer Progression. Cancers (Basel) 2021;13:4151. [PMID: 34439303 DOI: 10.3390/cancers13164151] [Reference Citation Analysis]
42 Correa E, Lindsay T, Dotan E. Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies. Drugs Aging 2021;38:639-54. [PMID: 34143421 DOI: 10.1007/s40266-021-00869-z] [Reference Citation Analysis]